Infusion Therapy in the Treatment of Neuropathic Pain

Preston R. McMullin, Alexander Thomas Hynes, Mohammed Ahnaf Arefin, Moawiz Saeed, Sarvani Gandhavadi, Nuha Arefin, Maxim S. Eckmann

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose of Review: Neuropathic pain is a prevalent and burdensome condition. While oral medical therapies are the first-line treatment for refractory neuropathic pain, in some cases, infusion therapy may be employed. This article is a systematic review of recent publications regarding epidemiologic, pathophysiologic, diagnostic, and therapeutic advancements in the treatment of neuropathic pain using intravenous infusion therapy. Special consideration will be given to relevant and practically used agents and available information on outcomes. Recent Findings: Individuals with neuropathic pain from various etiologies (e.g. trigeminal neuralgia, post-herpetic neuralgia, diabetic neuropathy) often find short-term relief from infusion therapies. However, it is difficult to generalize the findings of these studies to form a standard treatment regimen. Summary: The purpose of this paper is to provide clinicians an up-to-date summary of recent literature regarding several infusion therapies in treating neuropathic pain.

Original languageEnglish (US)
Pages (from-to)693-699
Number of pages7
JournalCurrent Pain and Headache Reports
Volume26
Issue number9
DOIs
StatePublished - Sep 2022

Keywords

  • Infusion therapy
  • Ketamine
  • Lidocaine
  • Magnesium
  • Neuropathy
  • Vitamin B12

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Infusion Therapy in the Treatment of Neuropathic Pain'. Together they form a unique fingerprint.

Cite this